Sat-18-12-2021, 22:10 PM
Rinvoq goes for psoriatic arthritis approval
|
Thu-13-01-2022, 14:27 PM
Update: The National Institute for Health and Care Excellence (NICE) has recommended Rinvoq (upadacitinib) as a treatment option for certain patients with active psoriatic arthritis (PsA) in England and Wales.
Mon-17-01-2022, 21:12 PM
(Thu-13-01-2022, 14:27 PM)Fred Wrote: Update: The National Institute for Health and Care Excellence (NICE) has recommended Rinvoq (upadacitinib) as a treatment option for certain patients with active psoriatic arthritis (PsA) in England and Wales.I'll keep my head down and hope it's never offered me as an option ![]() |
« Next Oldest | Next Newest »
|
Possibly Related Threads… | |||||
Thread | Author | Replies | Views | Last Post | |
![]() |
Metabolic syndrome more common in patients with psoriatic arthritis | Fred | 6 | 2,213 |
Yesterday, 20:51 PM Last Post: Caroline |
![]() |
Tapinarof gets FDA approval for psoriasis | Fred | 2 | 275 |
Tue-24-05-2022, 22:52 PM Last Post: KatT |
![]() |
Skyrizi goes for psoriatic arthritis | Fred | 9 | 2,459 |
Sat-22-01-2022, 14:47 PM Last Post: Caroline |
![]() |
Bimzelx psoriatic arthritis phase 3 results | Fred | 4 | 969 |
Sat-22-01-2022, 10:05 AM Last Post: Caroline |
![]() |
Cosentyx gets FDA approval for juvenile psoriatic arthritis | Fred | 1 | 715 |
Sun-26-12-2021, 21:04 PM Last Post: Caroline |
Users browsing this thread: 1 Guest(s)